Study Reference No. - C1D00719

Study Reference No. Study Type Compensation Gender Age Demographic
C1D00719 Healthy $2,625 Males and Females 18-65 Vasectomized or infertile males;
Non-childbearing females (surgical removal of reproductive parts or post-menopausal;
Non-smokers for at least the past 6 months
Study Details

Study Purpose

The purpose of this study is to evaluate the safety, tolerability and the amount of the study drug in your blood of VIRAZOLE (Ribavirin for Inhalation Solution, USP) in healthy volunteers.

Study Duration

Approx. 40 days total; 1 Period with 2 overnight stays and 2 returns

Study Schedule

General Screening


Medical Screening

Multiple screening dates starting March 12; contact Recruitment

Study Visit(s)

Multiple cohort dates starting March 23; contact Recruitment

Follow-Up Visit(s)


Other Notes

Bring Valid Photo ID.

COVID-19 test will be conducted prior to check-in.